title: Severe hemorrhagic colitis caused by dasatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia.
authors: Yamagata University School of Medicine, Department of Pediatrics, Yamagata 990-9585, Japan. simokaze@med.id.yamagata-u.ac.jp
authors: Tomoyuki
authors: T
authors: Shimokaze
authors: Tetsuo
authors: T
authors: Mitsui
authors: Hiroaki
authors: H
authors: Takeda
authors: Takako
authors: T
authors: Kawakami
authors: Takahiko
authors: T
authors: Arai
authors: Masafumi
authors: M
authors: Ito
authors: Akiko
authors: A
authors: Iwaba
authors: Hiroko
authors: H
authors: Izumino
authors: Noriyuki
authors: N
authors: Takahashi
authors: Miyako
authors: M
authors: Kanno
authors: Dai
authors: D
authors: Sendo
authors: Kiyoshi
authors: K
authors: Hayasaka
mesh_terms: D016026:Bone Marrow Transplantation; D002648:Child; D003092:Colitis / Q000139:chemically induced* / Q000188:drug therapy; D003113:Colonoscopy; D003131:Combined Modality Therapy; D000069439:Dasatinib; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D013844:Thiazoles / Q000009:adverse effects*
chemical_list: D011743:Pyrimidines; D013844:Thiazoles; D011505:Protein-Tyrosine Kinases; D000069439:Dasatinib